Mechanistic IS/ID Modeling to Enable Pediatric Vaccine Dose Selection: A Case Study in Predictive Immunogenicity Accelerating Innovation to Optimize Dosing & Speed Up Time-to-Market
- Learn how mechanistic IS/ID modeling can be applied to inform pediatric vaccine dose selection with predictive confidence
- Understand how model-informed development streamlines clinical trial design and supports regulatory interactions
- Gain actionable insights into implementing scalable modeling strategies to accelerate vaccine development across age groups